^○Hajime MIYANISHI¹, Kyosuke UNO^{1, 2}, Shin-ichi MURAMATSU^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, Toyama Unuversity, Toyama, 2. Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan, 3. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 4. Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Hiromi ABE^{1, 2}, Naoto KAJITANI¹, Mami OKADA-TSUCHIOKA ¹, Wataru OMORI¹, Masahide YATSUMOTO², Minoru TAKEBAYASHI^{1, 3} (1. Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, 2. Department of Pharmacy, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Japan, 3. Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan)

^○Yuma NAGAI¹, Kazuki NAGAYASU¹, Konomi MASUNAKA², Yukio AGO^{2, 3}, Atsushi KASAI², Hisashi SHIRAKAWA¹, Takanobu NAKAZAWA^{2, 4}, Hitoshi HASHIMOTO^{2, 5, 6, 7}, Shuji KANEKO¹ (1. Department of Molecular Pharmacology Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, 2. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. Laboratory of Molecular Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 4. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 5. Molecular Research Center of Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, 6. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 7. Open and Transdisciplinary Research Intiatives, Osaka University, Osaka, Japan)

^○Yosuke YAMAWAKI^{1, 2}, Satomi SHIRAWACHI², Munechika TAKAISHI², Shigeto YAMAWAKI³, Takashi KANEMATSU^{2, 4} (1. Department of Advanced Pharmacology, Daiichi University of Pharmacy, Fukuoka, Japan, 2. Department of Cellular and Molecular Pharmacology Institute of Biomedical and Health Sciences Hiroshima University, Hiroshima, Japan, 3. Office of Industry-Academia-Government and Community Collaboration Institute of Biomedical and Health Sciences Hiroshima Univesity, Hiroshima, Japan, 4. Department of Cell Biology and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan)

^○Saya ARAKAKI, Keisuke SAKASAI, Natsuko HITORA-IMAMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan)

^○Minoru TSUJI, Kazuhiro KUROKAWA, Kazuya MIYAGAWA, Atsumi MOCHIDA-SAITO, Hiroshi TAKEDA (Department of Pharmacology, School of Pharmacy, International University of Health and Welfare)

^○Daiki UEDA¹, Aimi YAMAGISHI¹, Naomi YONEMOCHI¹, Junzo KAMEI², Hiroko IKEDA¹ (1. Department of Pathophysiology and Therapeutics, Hoshi University, Tokyo, Japan, 2. Department of Biomolecular Pharmacology, Hoshi University, Tokyo, Japan)